Skip to Content

M RE8 (Ropinirole Hydrochloride Extended-Release 8 mg)

Pill with imprint M RE8 is Red, Round and has been identified as Ropinirole Hydrochloride Extended-Release 8 mg. It is supplied by Mylan Pharmaceuticals Inc..

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M RE8

Ropinirole hydrochloride extended-release 8 mg M RE8

Ropinirole Hydrochloride Extended-Release

Imprint:
M RE8
Strength:
8 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
ethylcelluloses
FD&C Red No. 40
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
propylene glycol
FD&C Blue No. 2
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide